Marienke M. De Bruijn
Tilburg, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
High Relapse Rate in Anti-CASPR2 Disease: Implications for Prolonged Immunotherapy.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 16, 2025
A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.
Journal: Annals of neurology
Published: December 05, 2025
A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.
Journal: Annals of neurology
Published: December 05, 2025
Movement Disorders in Antibody-Associated Neurologic Diseases: A Nationwide Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: November 21, 2025
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.
Journal: The Lancet regional health. Europe
Published: July 24, 2025
Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes: A Nationwide Study on Epidemiology and Antibody Testing Performance.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 28, 2024
HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis.
Journal: Frontiers in immunology
Published: April 25, 2024
Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
Journal: Neurology
Published: June 30, 2022
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes.
Journal: Neuro-oncology advances
Published: October 25, 2021
Last Updated: 09/26/2026